UK shareholders in AstraZeneca have pointed to the positives of a potential tie-up with US drugs giant Pfizer, a sign that could be of crucial significance in a so-far frosty bid process.

This morning Pfizer confirmed it had contacted AstraZeneca for a second time with regards to a potential acquisition, having first tabled a bid in January this year.